I don't know what snapshot in time, I don't know what basket of drugs was being studied, so we have to be careful.
This is what we're saying about looking at any statistics. We have to look at the baskets being compared. It may not be the same basket that goes through the common drug review. To be frank, I don't know what the basket is in the 62% and the 15%, because what we heard from Mr. Nakagawa was that they are following all the recommendations.
So it is confusing.